Mutual Funds

Mirae Asset Healthcare Fund-Reg(G)
Equity | Very High | Equity - Sectoral Fund - Pharma & Health Care

46.31 -0.05
NAV(₹) as on 10/9/2026

-0.11%
1D

18.63%
1Y

21.36%
3Y

14.28%
5Y

Mirae Asset Healthcare Fund-Reg(G)
Growth Chart of the Scheme

Scheme Details
Expense Ratio: 2.04	Launch Date: 02 Jul 2018
Exit Load: 1% on or before 30D, NIL after 30D	AUM: ₹ 3,555.18 Crs
Lock-in: Nil	Investing Style: Large Growth
Portfolio Price To Book Value: 9.07	Min. Investment: SIP : ₹ 99.00 Lumpsum : ₹ 5,000.00
Scheme Benchmark: NA
Fund Manager: Vrijesh Kasera ,Tanmay Mehta

FUND OBJECTIVE

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies/Entities benefitting directly or indirectly in Healthcare and allied sectors in India. The Scheme does not guarantee or assure any returns. There is no assurance that the investment objective of the Scheme will be achieved.

LATEST ASSET & PORTFOLIO ALLOCATION		Others		Equity
as on 31/8/2026		0.33 %		99.67 %

TOP HOLDINGS

Sun Pharmaceutical Industries Ltd.

10.90 %

Divi's Laboratories Ltd.

9.91 %

Torrent Pharmaceuticals Ltd.

7.06 %

Apollo Hospitals Enterprise Ltd.

5.91 %

Laurus Labs Ltd.

5.24 %

Glenmark Pharmaceuticals Ltd.

4.99 %

Dr. Reddy's Laboratories Ltd.

3.94 %

Aurobindo Pharma Ltd.

3.81 %

Ipca Laboratories Ltd.

3.43 %

Fortis Healthcare Ltd.

3.40 %

See All Holding

ALLOCATION BY MARKET CAP (Equity)

ALLOCATION BY RATING (Debt & Others)

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs

75.40 %

Hospital & Healthcare Servic

21.74 %

Medical Equipment/Supplies/A

1.44 %

Chemicals

1.09 %

See All Sectors

PORTFOLIO CHARACTERISTICS (Debt)

No Data

5 YEAR HISTORY

Financial Year	2021-22	2022-23	2023-24	2024-25	2025-26
NAV (31/3/2026)	22.38	20.12	31.14	36.51	37.82
Net Assets (Rs Crores)	1,81,746.81	1,51,339.70	2,23,515.14	2,66,739.52	2,75,372.49
Scheme Returns(%)(Absolute)	18.45	-9.89	54.74	16.01	5.71
B'mark Returns(%)(Absolute)	NA	NA	NA	NA	NA
Category Rank	34/75	69/76	23/90	8/102	13/120

RISKOMETER
Level of Risk in the Scheme

Clients will understand that their principal will be at Very High risk.

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Fund Details	Inception Date	Aum(₹ Crs)	1Y	3Y	5Y	Since Inception
HDFC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 22.03 +0.06	4/10/2023	₹ 3,310.64	26.85%	-	-	31.02%
WOC Pharma and Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 17.05 +-0.01	6/2/2024	₹ 902.24	21.46%	-	-	22.84%
PGIM India Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 12.16 +-0.05	6/12/2024	₹ 125.15	22.95%	-	-	11.74%
Bajaj Finserv Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.94 +-0.04	27/12/2024	₹ 405.91	21.18%	-	-	10.98%
Baroda BNP Paribas Health and Wellness Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 10.75 +-0.02	27/6/2025	₹ 507.42	9.63%	-	-	6.17%
Bandhan Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 11.32 +-0.04	28/11/2025	₹ 331.57	-	-	-	13.21%
Kotak Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 17.32 +0.13	11/12/2023	₹ 682.39	27.21%	-	-	22.09%
Nippon India Pharma Fund(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 568.60 +-3.24	5/6/2004	₹ 9,479.08	10.35%	17.72%	12.66%	19.88%
ITI Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 18.13 +-0.08	8/11/2021	₹ 276.23	10.57%	17.80%	-	13.08%
Tata India Pharma & Healthcare Fund-Reg(G) Equity - Sectoral Fund - Pharma & Health Care \| Very High \| 33.37 +-0.09	28/12/2015	₹ 1,565.28	7.92%	18.20%	13.04%	11.91%